CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 197 of 644
Non-Antibody Products
Page 197 of 644
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| DMHAPC-Chol | A cationic cholesterol; a component of liposomes used for DNA plasmid deli… | 1 mg | 26582-1 | More Info |
| DMHAPC-Chol | A cationic cholesterol; a component of liposomes used for DNA plasmid deli… | 10 mg | 26582-10 | More Info |
| DMHAPC-Chol | A cationic cholesterol; a component of liposomes used for DNA plasmid deli… | 25 mg | 26582-25 | More Info |
| DMHAPC-Chol | A cationic cholesterol; a component of liposomes used for DNA plasmid deli… | 5 mg | 26582-5 | More Info |
| DMHCA | An LXR agonist; activates LXRα and LXRβ in CV-1 cells expressin… | 1 mg | 37712-1 | More Info |
| DMHCA | An LXR agonist; activates LXRα and LXRβ in CV-1 cells expressin… | 10 mg | 37712-10 | More Info |
| DMHCA | An LXR agonist; activates LXRα and LXRβ in CV-1 cells expressin… | 25 mg | 37712-25 | More Info |
| DMHCA | An LXR agonist; activates LXRα and LXRβ in CV-1 cells expressin… | 5 mg | 37712-5 | More Info |
| DM4 (hydrate) | A derivative of maytansine; cytotoxic to SK-BR-3 cells (IC50 = 3.3 nM); se… | 10 mg | 34121-10 | More Info |
| DM4 (hydrate) | A derivative of maytansine; cytotoxic to SK-BR-3 cells (IC50 = 3.3 nM); se… | 25 mg | 34121-25 | More Info |
| DM4 (hydrate) | A derivative of maytansine; cytotoxic to SK-BR-3 cells (IC50 = 3.3 nM); se… | 5 mg | 34121-5 | More Info |
| DM4 (hydrate) | A derivative of maytansine; cytotoxic to SK-BR-3 cells (IC50 = 3.3 nM); se… | 50 mg | 34121-50 | More Info |
| D-(−)-3-Phosphoglyceric Acid (sodium salt) | An intermediate in glycolysis / gluconeogenesis and the biosynthesis of se… | 1 g | 20123-1 | More Info |
| D-(−)-3-Phosphoglyceric Acid (sodium salt) | An intermediate in glycolysis / gluconeogenesis and the biosynthesis of se… | 10 mg | 20123-10 | More Info |
| D-(−)-3-Phosphoglyceric Acid (sodium salt) | An intermediate in glycolysis / gluconeogenesis and the biosynthesis of se… | 100 mg | 20123-100 | More Info |
| D-(−)-3-Phosphoglyceric Acid (sodium salt) | An intermediate in glycolysis / gluconeogenesis and the biosynthesis of se… | 50 mg | 20123-50 | More Info |
| D-(−)-Quinic Acid | A hydroxylated cyclohexane carboxylic acid with diverse biological activit… | 10 g | 30212-10 | More Info |
| D-(−)-Quinic Acid | A hydroxylated cyclohexane carboxylic acid with diverse biological activit… | 100 g | 30212-100 | More Info |
| D-(−)-Quinic Acid | A hydroxylated cyclohexane carboxylic acid with diverse biological activit… | 25 g | 30212-25 | More Info |
| D-(−)-Quinic Acid | A hydroxylated cyclohexane carboxylic acid with diverse biological activit… | 50 g | 30212-50 | More Info |
| D-(−)-Tagatose | A natural non-caloric sweetener and hexose monosaccharide; metabolized by… | 1 g | 39233-1 | More Info |
| D-(−)-Tagatose | A natural non-caloric sweetener and hexose monosaccharide; metabolized by… | 10 g | 39233-10 | More Info |
| D-(−)-Tagatose | A natural non-caloric sweetener and hexose monosaccharide; metabolized by… | 25 g | 39233-25 | More Info |
| D-(−)-Tagatose | A natural non-caloric sweetener and hexose monosaccharide; metabolized by… | 5 g | 39233-5 | More Info |
| 2,5-DMMA | A designer drug that combines the 2,5 disubstitution pattern of 2,5-dimeth… | 10 mg | 15131-10 | More Info |
| 2,5-DMMA | A designer drug that combines the 2,5 disubstitution pattern of 2,5-dimeth… | 5 mg | 15131-5 | More Info |
| 2,5-DMMA | A designer drug that combines the 2,5 disubstitution pattern of 2,5-dimeth… | 50 mg | 15131-50 | More Info |
| 3,4-DMMA (hydrochloride) | An MDMA analog that appears to act as a serotonin-norepinephrine-dopamine… | 10 mg | 11128-10 | More Info |
| 3,4-DMMA (hydrochloride) | An MDMA analog that appears to act as a serotonin-norepinephrine-dopamine… | 5 mg | 11128-5 | More Info |
| 3,4-DMMA (hydrochloride) | An MDMA analog that appears to act as a serotonin-norepinephrine-dopamine… | 50 mg | 11128-50 | More Info |
| DMNQ | A 1,4-naphthoquinone that acts as a redox-cycling agent, typically increas… | 10 mg | 19571-10 | More Info |
| DMNQ | A 1,4-naphthoquinone that acts as a redox-cycling agent, typically increas… | 25 mg | 19571-25 | More Info |
| DMNQ | A 1,4-naphthoquinone that acts as a redox-cycling agent, typically increas… | 5 mg | 19571-5 | More Info |
| DMOG | A cell permeable, competitive inhibitor of HIF-1α prolyl hydroxylase… | 10 mg | 71210-10 | More Info |
| DMOG | A cell permeable, competitive inhibitor of HIF-1α prolyl hydroxylase… | 100 mg | 71210-100 | More Info |
| DMOG | A cell permeable, competitive inhibitor of HIF-1α prolyl hydroxylase… | 50 mg | 71210-50 | More Info |
| DMOG | A cell permeable, competitive inhibitor of HIF-1α prolyl hydroxylase… | 500 mg | 71210-500 | More Info |
| DMP 543 | An inhibitor of Kv7.2 (IC50 = 0.048 µM); enhances potassium-induced… | 1 mg | 32849-1 | More Info |
| DMP 543 | An inhibitor of Kv7.2 (IC50 = 0.048 µM); enhances potassium-induced… | 10 mg | 32849-10 | More Info |
| DMP 543 | An inhibitor of Kv7.2 (IC50 = 0.048 µM); enhances potassium-induced… | 5 mg | 32849-5 | More Info |
| DMPAC-Chol | A cationic cholesterol derivative; has been used in liposome formation for… | 1 mg | 26583-1 | More Info |
| DMPAC-Chol | A cationic cholesterol derivative; has been used in liposome formation for… | 10 mg | 26583-10 | More Info |
| DMPAC-Chol | A cationic cholesterol derivative; has been used in liposome formation for… | 5 mg | 26583-5 | More Info |
| DMPE-MPEG(2000) | A PEGylated form of DMPE; has been used in the synthesis of NLCs for use i… | 10 mg | 34649-10 | More Info |
| DMPE-MPEG(2000) | A PEGylated form of DMPE; has been used in the synthesis of NLCs for use i… | 100 mg | 34649-100 | More Info |
| DMPE-MPEG(2000) | A PEGylated form of DMPE; has been used in the synthesis of NLCs for use i… | 250 mg | 34649-250 | More Info |
| DMPE-MPEG(2000) | A PEGylated form of DMPE; has been used in the synthesis of NLCs for use i… | 50 mg | 34649-50 | More Info |
| DMPO | A commonly-used spin trap; reacts with O-, N-, S-, and C-centered radicals… | 1 g | 10006436-1 | More Info |
| DMPO | A commonly-used spin trap; reacts with O-, N-, S-, and C-centered radicals… | 5 g | 10006436-5 | More Info |
| DMPO | A commonly-used spin trap; reacts with O-, N-, S-, and C-centered radicals… | 500 mg | 10006436-500 | More Info |
| DMPQ (hydrochloride) | A potent inhibitor of human PDGFRβ (IC50 = 80 nM) | 1 mg | 17551-1 | More Info |
| DMPQ (hydrochloride) | A potent inhibitor of human PDGFRβ (IC50 = 80 nM) | 10 mg | 17551-10 | More Info |
| DMPQ (hydrochloride) | A potent inhibitor of human PDGFRβ (IC50 = 80 nM) | 5 mg | 17551-5 | More Info |
| DM1-SMCC | An antibody-drug conjugate containing the maytansinoid DM1 and the crossli… | 1 mg | 23926-1 | More Info |
| DM1-SMCC | An antibody-drug conjugate containing the maytansinoid DM1 and the crossli… | 10 mg | 23926-10 | More Info |
| DM1-SMCC | An antibody-drug conjugate containing the maytansinoid DM1 and the crossli… | 25 mg | 23926-25 | More Info |
| DM1-SMCC | An antibody-drug conjugate containing the maytansinoid DM1 and the crossli… | 5 mg | 23926-5 | More Info |
| DM1-SMe | A mertansine analog; has in vitro activity against the PPTP panel of cance… | 1 mg | 22477-1 | More Info |
| DM1-SMe | A mertansine analog; has in vitro activity against the PPTP panel of cance… | 10 mg | 22477-10 | More Info |
| DM1-SMe | A mertansine analog; has in vitro activity against the PPTP panel of cance… | 25 mg | 22477-25 | More Info |
| DM1-SMe | A mertansine analog; has in vitro activity against the PPTP panel of cance… | 5 mg | 22477-5 | More Info |
| DMU2105 | A CYP1B1 inhibitor (IC50 = 0.01 µM); selective for CYP1B1 over CYP1A… | 10 mg | 38522-10 | More Info |
| DMU2105 | A CYP1B1 inhibitor (IC50 = 0.01 µM); selective for CYP1B1 over CYP1A… | 25 mg | 38522-25 | More Info |
| DMU2105 | A CYP1B1 inhibitor (IC50 = 0.01 µM); selective for CYP1B1 over CYP1A… | 5 mg | 38522-5 | More Info |
| DMU2105 | A CYP1B1 inhibitor (IC50 = 0.01 µM); selective for CYP1B1 over CYP1A… | 50 mg | 38522-50 | More Info |
| DMU2139 | A CYP1B1 inhibitor (IC50 = 0.009 µM); selective for CYP1B1 over CYP1… | 10 mg | 37301-10 | More Info |
| DMU2139 | A CYP1B1 inhibitor (IC50 = 0.009 µM); selective for CYP1B1 over CYP1… | 25 mg | 37301-25 | More Info |
| DMU2139 | A CYP1B1 inhibitor (IC50 = 0.009 µM); selective for CYP1B1 over CYP1… | 5 mg | 37301-5 | More Info |
| DMU2139 | A CYP1B1 inhibitor (IC50 = 0.009 µM); selective for CYP1B1 over CYP1… | 50 mg | 37301-50 | More Info |
| DMXAA | A tumor vascular disrupting agent, inducing apoptosis in tumor vascular en… | 1 mg | 14617-1 | More Info |
| DMXAA | A tumor vascular disrupting agent, inducing apoptosis in tumor vascular en… | 10 mg | 14617-10 | More Info |
| DMXAA | A tumor vascular disrupting agent, inducing apoptosis in tumor vascular en… | 25 mg | 14617-25 | More Info |
| DMXAA | A tumor vascular disrupting agent, inducing apoptosis in tumor vascular en… | 5 mg | 14617-5 | More Info |
| D-myo-Inositol-1,2-diphosphate (sodium salt) | A member of the InsP family of small, soluble second messengers | 1 mg | 10008439-1 | More Info |
| D-myo-Inositol-1,2-diphosphate (sodium salt) | A member of the InsP family of small, soluble second messengers | 100 µg | 10008439-100 | More Info |
| D-myo-Inositol-1,2-diphosphate (sodium salt) | A member of the InsP family of small, soluble second messengers | 500 µg | 10008439-500 | More Info |
| D-myo-Inositol-1,3-diphosphate (sodium salt) | Ins(1,3)P2 can be dephosphorylated to Ins(1)P by inositol polyphosphate 3-… | 1 mg | 10008443-1 | More Info |
| D-myo-Inositol-1,3-diphosphate (sodium salt) | Ins(1,3)P2 can be dephosphorylated to Ins(1)P by inositol polyphosphate 3-… | 100 µg | 10008443-100 | More Info |
| D-myo-Inositol-1,3-diphosphate (sodium salt) | Ins(1,3)P2 can be dephosphorylated to Ins(1)P by inositol polyphosphate 3-… | 500 µg | 10008443-500 | More Info |
| D-myo-Inositol-1,4-diphosphate (sodium salt) | Ins(1,4)P2 can be dephosphorylated to Ins(4)P by inositol polyphosphate 1-… | 1 mg | 10008438-1 | More Info |
| D-myo-Inositol-1,4-diphosphate (sodium salt) | Ins(1,4)P2 can be dephosphorylated to Ins(4)P by inositol polyphosphate 1-… | 100 µg | 10008438-100 | More Info |
| D-myo-Inositol-1,4-diphosphate (sodium salt) | Ins(1,4)P2 can be dephosphorylated to Ins(4)P by inositol polyphosphate 1-… | 500 µg | 10008438-500 | More Info |
| D-myo-Inositol-1,5-diphosphate (sodium salt) | Ins(1,5)P2 is a member of the inositol phosphate (InsP) molecular family t… | 1 mg | 10008441-1 | More Info |
| D-myo-Inositol-1,5-diphosphate (sodium salt) | Ins(1,5)P2 is a member of the inositol phosphate (InsP) molecular family t… | 100 µg | 10008441-100 | More Info |
| D-myo-Inositol-1,5-diphosphate (sodium salt) | Ins(1,5)P2 is a member of the inositol phosphate (InsP) molecular family t… | 500 µg | 10008441-500 | More Info |
| D-myo-Inositol-2,4-diphosphate (sodium salt) | An intermediate compound produced by the dephosphorylation of either Ins-2… | 1 mg | 10008419-1 | More Info |
| D-myo-Inositol-2,4-diphosphate (sodium salt) | An intermediate compound produced by the dephosphorylation of either Ins-2… | 100 µg | 10008419-100 | More Info |
| D-myo-Inositol-2,4-diphosphate (sodium salt) | An intermediate compound produced by the dephosphorylation of either Ins-2… | 500 µg | 10008419-500 | More Info |
| D-myo-Inositol-4,5-diphosphate (sodium salt) | Ins(4,5)P2 is a metabolite of Ins(1,4,5)P3 that lacks a phosphate at the 1… | 1 mg | 10008418-1 | More Info |
| D-myo-Inositol-4,5-diphosphate (sodium salt) | Ins(4,5)P2 is a metabolite of Ins(1,4,5)P3 that lacks a phosphate at the 1… | 100 µg | 10008418-100 | More Info |
| D-myo-Inositol-4,5-diphosphate (sodium salt) | Ins(4,5)P2 is a metabolite of Ins(1,4,5)P3 that lacks a phosphate at the 1… | 500 µg | 10008418-500 | More Info |
| D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (sodium salt) | An inositol phosphate with antioxidant and anticancer activities; chelates… | 1 mg | 10008415-1 | More Info |
| D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (sodium salt) | An inositol phosphate with antioxidant and anticancer activities; chelates… | 10 mg | 10008415-10 | More Info |
| D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (sodium salt) | An inositol phosphate with antioxidant and anticancer activities; chelates… | 5 mg | 10008415-5 | More Info |
| D-myo-Inositol-1,2,3,4,5,6-hexaphosphate (sodium salt) | An inositol phosphate with antioxidant and anticancer activities; chelates… | 500 µg | 10008415-500 | More Info |
| D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) | A member of the inositol phosphate (InsP) family of small, soluble second… | 1 mg | 10009851-1 | More Info |
| D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) | A member of the inositol phosphate (InsP) family of small, soluble second… | 100 µg | 10009851-100 | More Info |
| D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) | A member of the inositol phosphate (InsP) family of small, soluble second… | 500 µg | 10009851-500 | More Info |
| D-myo-Inositol-1,2,3,5,6-pentaphosphate (sodium salt) | A member of the inositol phosphate family of small, soluble second messeng… | 1 mg | 10008453-1 | More Info |
| D-myo-Inositol-1,2,3,5,6-pentaphosphate (sodium salt) | A member of the inositol phosphate family of small, soluble second messeng… | 100 µg | 10008453-100 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile